KoBioLabs

KoBioLabs Capital Expenditures

The Capital Expenditures (CapEx) of KoBioLabs (348150.KQ) as of Nov 16, 2026 is -552.91 M KRW. In the previous year, Capital Expenditures (CapEx) was -1.65 B KRW — a change of -66.42% (higher).

Capital Expenditures

-552.91 MKRW

YoY

-66.42%

Last updated:

Capital Expenditures (CapEx) of KoBioLabs is 2025 -552.91 M KRW. Capital Expenditures (CapEx) of KoBioLabs was 2024 -1.65 B KRW. It decreases by -66.42% higher compared to the previous year.

The KoBioLabs Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-295.88 M KRW
Jan 1, 2019
-290.16 M KRW
Jan 1, 2020
-124.98 M KRW
Jan 1, 2021
-5.55 B KRW
Jan 1, 2022
-14.76 B KRW
Jan 1, 2023
-15.56 B KRW
Jan 1, 2024
-1.65 B KRW
Jan 1, 2025
-552.91 M KRW
The KoBioLabs Capital Expenditures history
YEARCapital ExpendituresYoY
-552.91 MKRW-66.42%
-1.65 BKRW-89.42%
-15.56 BKRW+5.40%
-14.76 BKRW+165.97%
-5.55 BKRW+4,341.80%
-124.98 MKRW-56.93%
-290.16 MKRW-1.93%
-295.88 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Capital Expenditures (CapEx) of KoBioLabs is -552.91 M KRW in 2025.

Capital Expenditures (CapEx) of KoBioLabs changed from -1.65 B KRW to -552.91 M KRW, representing a -66.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s KoBioLabs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — KoBioLabs

All Key Metrics — KoBioLabs